Price to Book Value Chart

Historical Price to Book Value Data

View and export this data back to 2000. Start Trial.
Date Value
October 16, 2026 0.169
October 15, 2026 0.2109
October 14, 2026 0.249
October 13, 2026 0.2553
October 12, 2026 0.267
October 09, 2026 0.2786
October 08, 2026 0.2945
October 07, 2026 0.3058
October 06, 2026 0.3109
October 05, 2026 0.3275
October 02, 2026 0.3335
October 01, 2026 0.3448
September 30, 2026 0.3483
September 29, 2026 0.3441
September 28, 2026 0.3451
September 25, 2026 0.3445
September 24, 2026 0.365
September 23, 2026 0.3952
September 22, 2026 0.4151
September 21, 2026 0.4046
September 18, 2026 0.4151
September 17, 2026 0.4525
September 16, 2026 0.4649
September 15, 2026 0.4691
September 14, 2026 0.4649
Date Value
September 11, 2026 0.4691
September 10, 2026 0.4815
September 09, 2026 0.4981
September 08, 2026 0.5272
September 04, 2026 0.5604
September 03, 2026 0.5687
September 02, 2026 0.5729
September 01, 2026 0.5895
August 31, 2026 0.6185
August 28, 2026 0.6185
August 27, 2026 0.6227
August 26, 2026 0.6393
August 25, 2026 0.66
August 24, 2026 0.6559
August 21, 2026 0.6559
August 20, 2026 0.6683
August 19, 2026 0.714
August 18, 2026 0.7057
August 17, 2026 0.7472
August 14, 2026 0.7472
August 13, 2026 0.7763
August 12, 2026 0.6933
August 11, 2026 0.9589
August 10, 2026 1.519
August 07, 2026 1.669

Price to Book Ratio Definition

Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.

Read full definition.

Price to Book Value Range, Past 5 Years

View Price to Book Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price to Book Value Benchmarks

View Price to Book Value Benchmarks
Start Trial
Agenus, Inc. --
Amgen, Inc. 20.00
Anika Therapeutics, Inc. 1.948
BioCryst Pharmaceuticals, Inc. --
Imunon, Inc. 1.136

Price to Book Value Related Metrics

PS Ratio 0.1103
Price 0.4071
Earnings Yield -3.51K%
Market Cap 0.7934M